ViaNautis Bio appoints Dr Steven M Altschuler as Chairman of its Board of Directors tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Now That s A Good Deed! Singer Donates $50,000 To Children s Hospital her.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from her.ie Daily Mail and Mail on Sunday newspapers.
Corner Therapeutics Debuts with Data Presentation on its Dendritic Cell Hyperactivation Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Published: Jan 28, 2021
WATERTOWN, Mass. (BUSINESS WIRE) PlateletBio, a pioneering biotechnology company developing next-generation allogeneic cell therapies for treatment of human diseases, has named Steven M. Altschuler, M.D., as Chairman of its Board of Directors.
“As a clinician, healthcare administrator, biotech entrepreneur and venture capital investor, Steve’s leadership and breadth of experience in the clinical development of cell and gene therapies will be invaluable to PlateletBio as we progress our cell therapy platform into the clinic later this year,” said Sam Rasty, Ph.D., President and CEO of PlateletBio. “We will benefit tremendously from Steve’s clinical leadership experience, including serving as CEO of both the Children’s Hospital of Philadelphia and the University of Miami Health System, as we continue to advance PlateletBio into its next phase of growth as a clinical stage company.”